logo 2.png
STRIDE Fitness Tustin to Hold Global Running Day Celebration featuring Health Experts, Competitions, and Prize Giveaways
June 06, 2023 17:43 ET | STRIDE Fitness Addison
TUSTIN, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- STRIDE Fitness Tustin, a premium boutique fitness studio and member of the Xponential Fitness (NYSE: XPOF) family of brands, is hosting a Global...
TIP_link_300x300.jpg
$881.28 Mn, Resistance Bands Market to Grow at 4.5% CAGR, Globally, by 2028 - Rising Popularity of Strength Training | Comprehensive Analysis by The Insight Partners
February 09, 2023 09:18 ET | The Insight Partners
New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Resistance Bands Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis...
CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx Launches a new Barostim™ Programmer
July 12, 2022 08:30 ET | CVRx, Inc.
MINNEAPOLIS, July 12, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure, has...
Roots-Analysis-Logo.png
The novel cardiovascular drug delivery devices market is projected to grow at a CAGR of 9.3%, till 2035, claims Roots Analysis
July 05, 2022 10:09 ET | Roots Analysis
London, July 05, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Novel Cardiovascular Drug Delivery Devices Market, 2022-2035” report to its list of offerings. In order to...
CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System
May 09, 2022 08:30 ET | CVRx, Inc.
Heart failure patients implanted with Barostim can now receive conditional MRI scans MINNEAPOLIS, May 09, 2022 (GLOBE NEWSWIRE) --  CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), developer of the world’s...
TIP_link_300x300.jpg
Cardiometabolic Diseases Market Size ($121,804.49Mn by 2028) Lead by Cardiovascular Disease (3.9% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 29, 2021 09:54 ET | The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cardiometabolic Diseases Market: Key InsightsAccording to our new research study on Cardiometabolic Diseases Market Size and Forecast to 2028 - COVID-19...
SportsArt Partners with The Imaginarium at I-Square’s ECO gym
February 22, 2018 09:27 ET | SportsArt
ROCHESTER, N.Y., Feb. 22, 2018 (GLOBE NEWSWIRE) -- SportsArt today announces its partnership with The Imaginarium ECO Gym at I-Square.  I-Square is a mixed-use development complex that houses The...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies Announces Results of Independent Product Assessment Study for PURE EP System
October 26, 2017 08:00 ET | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 26, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization
October 24, 2017 08:00 ET | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 24, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022
October 19, 2017 08:00 ET | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 19, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within...